Work Group Membership.

WORK GROUP CO-CHAIRS

Adeera Levin, MD, FRCPC University of British Columbia Vancouver, Canada

Paul E Stevens, MB, FRCP East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom

WORK GROUP

Rudy W Bilous, MD Newcastle University and James Cook University Hospital Middlesbrough, United Kingdom

Josef Coresh, MD, PhD, MHS Johns Hopkins University Baltimore, USA

Angel LM de Francisco, MD, PhD Hospital Universitario Valdecilla Santander, Spain

Paul E de Jong, MD, PhD University Medical Center Groningen Groningen, The Netherlands

Kathryn E Griffith, BM, BS, MSc, MRCP, MRCGP University Health Centre, York University York, United Kingdom

Brenda R Hemmelgarn, MD, PhD, FRCP(C) University of Calgary Alberta, Canada

Kunitoshi Iseki, MD University Hospital of the Ryukyus Nishihara, Okinawa, Japan

Edmund J Lamb, PhD, FRCPath East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom

Andrew S Levey, MD Tufts Medical Center Boston, USA

Miguel C Riella, MD, PhD, FACP Evangelic University Hospital Curitiba, Brazil

Michael G Shlipak, MD, MPH VA Medical Center, UCSF San Francisco, USA

Haiyan Wang, MD Peking University First Hospital Beijing, China

Colin T White, MD, FRCPC University of British Columbia Vancouver, Canada

Christopher G Winearls, MB, DPhil, FRCP Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom

EVIDENCE REVIEW TEAM

Tufts Center for Kidney Disease Guideline Development and Implementation

Tufts Medical Center, Boston, MA, USA:

Katrin Uhlig, MD, MS, Project Director; Director, Guideline Development

Dana Miskulin, MD, MS, Staff Nephrologist

Amy Earley, BS, Project Coordinator

Shana Haynes, MS, DHSc, Research Assistant

Jenny Lamont, MS, Project Manager

In addition, support and supervision were provided by:

Ethan M Balk, MD, MPH; Program Director, Evidence Based Medicine